SaaS Metrics
Academic Publication Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
AI Semantic Synergy Context
Connecting this academic literature to real-world market discussions and products.
Analysis of cell-free DNA for cancer diagnostics using liquid biopsies
Chromatin organisation influences gene regulation and genome stability, yet its dysregulation in cancer remains incompletely understood. This has become particularly important for patient diagnosti...
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
AbstractCancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary field that is garnering a lot of interest and investigation. Nanomedicine shows great potential fo...
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
AbstractThe data sources and methods used to develop global cancer incidence and mortality statistics—the GLOBOCAN estimates—for the year 2022 are documented in this article, alongside a brief over...
The NHGRI-EBI GWAS Catalog: standards for reusability, sustainability and diversity
Abstract The NHGRI-EBI GWAS Catalog serves as a vital resource for the genetic research community, providing access to the most comprehensive database of human GWAS results. Curre...
Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer
Gastric cancer (GC) is one of the most common cancers worldwide. Most patients are diagnosed at the progressive stage of the disease, and current anticancer drug advancements are still lacking. The...
Frequently Asked Questions (FAQ)
Curated market intelligence mapped to this research.
What is the core focus of the research titled 'Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group'?
This literature focuses on:
Which startups are commercializing the technology behind Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group?
Products like LaReview are bringing this to market. Their focus is: Open-source free next-generation code review.
What other academic literature is closely related to 'Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group'?
Yes, highly correlated activity was mapped. An entry titled 'Analysis of cell-free DNA for cancer diagnostics using liquid biopsies' discusses this: Chromatin organisation influences gene regulation and genome stability, yet its dysregulation in cancer remains incompletely understood. This has b...
Cite this Market Intelligence Report
Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.
Commercial Realization
Startups and Open Source tools heavily associated with the concepts explored in this paper.
-
Product HuntLaReview
Associated Media Narrative
- First meeting of the IHR Emergency Committee regarding the epidemic of Ebola Bundibugyo virus disease in the Democratic Republic of the Congo and Uganda 2026 - Temporary recommendations
- Fugaku NEXT: The Counterattack of Japan's Homegrown Supercomputer
- Powered by Silicon Labs, Comminent Ships 500,000 Wi-SUN Modules